Transplant Reports : Open Access
Open Access

Corneal transplant reports; Eyes; DMEK

Introduction

Recent reports indicate significant progress in corneal transplantation techniques, leading to enhanced outcomes for patients. One notable advancement is the introduction of lamellar keratoplasty techniques, such as Descemet's stripping automated endothelial keratoplasty (DSAEK) and Descemet's membrane endothelial keratoplasty (DMEK). These procedures involve replacing only the diseased or damaged layers of the cornea, thereby reducing the risk of rejection and improving visual outcomes compared to traditional full-thickness transplants [1-3].

Methodology

Moreover, the use of advanced imaging technologies, such as anterior segment optical coherence tomography (AS-OCT) and specular microscopy, has revolutionized preoperative assessment and postoperative monitoring of corneal transplant recipients. These non-invasive imaging modalities provide detailed insights into corneal anatomy, endothelial cell density, and graft-host interface integrity, facilitating early detection of complications and timely intervention.

Another significant development in corneal transplantation is the growing emphasis on tissue engineering and regenerative medicine approaches. Researchers are exploring innovative techniques to bioengineer corneal tissues using synthetic scaffolds, stem cells, and growth factors. While still in the experimental stage, these bioengineered corneas hold immense potential for overcoming the limitations of donor tissue shortage and immune rejection, ultimately improving long-term graft survival [4-6].

Challenges and Limitations

Despite the remarkable progress in corneal transplantation, several challenges persist in the field. One major hurdle is the shortage of donor corneas, especially in developing countries where access to eye banks is limited. Efforts to increase awareness about eye donation and streamline the procurement and distribution process are essential to address this issue and meet the growing demand for corneal transplants worldwide.

Moreover, immune-mediated rejection remains a significant concern following corneal transplantation, particularly in high-risk patients with a history of multiple surgeries or pre-existing ocular inflammation. While advancements in immunosuppressive therapies have reduced the incidence of rejection, the long-term use of these medications poses risks of systemic side effects and opportunistic infections. Therefore, there is a need for targeted immunomodulatory strategies to achieve immune tolerance and minimize the reliance on long-term immunosuppression.

Additionally, the management of complications such as graft failure, infection, and endothelial cell loss continues to pose clinical challenges in corneal transplantation. Despite meticulous surgical techniques and postoperative care, unpredictable factors such as wound healing abnormalities and environmental factors can compromise graft survival. Early recognition and prompt intervention are crucial in mitigating these complications and optimizing visual outcomes for patients [7-9].

Future Directions

Looking ahead, ongoing research efforts aim to address the existing challenges and further improve the outcomes of corneal transplantation. Collaborative initiatives between clinicians, researchers, and industry partners are focused on developing novel therapies for enhancing graft survival, reducing the risk of rejection, and promoting tissue regeneration.

Furthermore, the integration of artificial intelligence (AI) and machine learning algorithms into corneal imaging and diagnostic tools holds promise for personalized treatment planning and prognostication. By analyzing vast datasets of clinical parameters and outcomes, AI-driven algorithms can help predict the likelihood of graft success, identify risk factors for complications, and optimize postoperative management strategies [10].

Discussion

Corneal transplantation remains a cornerstone in the treatment of corneal diseases, offering restored vision and improved quality of life for countless individuals worldwide. With ongoing advancements in surgical techniques, tissue engineering, and immunomodulatory therapies, the field of corneal transplantation is poised for continued growth and innovation. By addressing existing challenges and embracing emerging technologies, clinicians and researchers can further enhance the success rates and long-term outcomes of this life-changing procedure.

Recent reports on corneal transplantation highlight significant advancements and ongoing challenges in the field. With the introduction of innovative surgical techniques like lamellar keratoplasty and the integration of advanced imaging technologies, visual outcomes for patients have improved substantially. Moreover, the exploration of tissue engineering and regenerative medicine approaches offers promising avenues for overcoming donor tissue shortages and enhancing long-term graft survival. However, challenges such as the scarcity of donor corneas, immune-mediated rejection, and complications post-transplantation persist. Efforts to increase eye donation awareness, develop targeted immunomodulatory therapies, and mitigate complications are crucial in addressing these obstacles.

Conclusion

Looking to the future, collaborative research endeavors and the integration of artificial intelligence into diagnostic and therapeutic protocols hold promise for further optimizing outcomes in corneal transplantation. By addressing these challenges and embracing emerging technologies, the field can continue to evolve, providing renewed hope and improved quality of life for patients with corneal diseases worldwide.

References

1. Zielińska K, Kukulski L, Wróbel M, Przybyłowski P, Rokicka D, et al. (2022) Carbohydrate Metabolism Disorders in Relation to Cardiac Allograft Vasculopathy (CAV) Intensification in Heart Transplant Patients According to the Grading Scheme Developed by the International Society for Heart and Lung Transplantation (ISHLT). Ann Transplant 27: 933420.

Indexed at, Google Scholar, Crossref

2. Raffa GM, Di Gesaro G, Sciacca S, Tuzzolino F, Turrisi M, et al. (2016) Heart transplant program at IRCCS-ISMETT: Impact of mechanical circulatory support on pre- and post -transplant survival. Int J Cardiol 219: 358-361.

Indexed at, Google Scholar, Crossref

3. Kitamura S (2012) Heart transplantation in Japan: a critical appraisal for the results and future prospects. Gen Thorac Cardiovasc Surg 60: 639-644.

Indexed at, Google Scholar, Crossref

4. Delgado JF, Reyne AG, de Dios S, López-Medrano F, Jurado A, et al. (2015) Influence of cytomegalovirus infection in the development of cardiac allograft vasculopathy after heart transplantation. J Heart Lung Transplant 3:1112-1119.

Indexed at, Google Scholar, Crossref

5. Wever-Pinzon O, Edwards LB, Taylor DO, Kfoury AG, Drakos SG, et al. (2017) Association of recipient age and causes of heart transplant mortality: Implications for personalization of post-transplant management-An analysis of the International Society for Heart and Lung Transplantation Registry. J Heart Lung Transplant 36: 407-417.

Indexed at, Google Scholar, Crossref

6. Saczkowski R, Dacey C, Bernier PL (2010) Does ABO-incompatible and ABO-compatible neonatal heart transplant have equivalent survival. Interact Cardiovasc Thorac Surg 10: 1026-1033.

Indexed at, Google Scholar, Crossref

7. Jeewa A, Manlhiot C, Kantor PF, Mital S, McCrindle BW, et al. (2014) Risk factors for mortality or delisting of patients from the pediatric heart transplant waiting list. J Thorac Cardiovasc Surg 147: 462-468.

Indexed at, Google Scholar, Crossref

8. Conway J, Manlhiot C, Kirk R, Edwards LB, McCrindle BW, et al. Mortality and morbidity after retransplantation after primary heart transplant in childhood: an analysis from the registry of the International Society for Heart and Lung Transplantation. J Heart Lung Transplant 33: 241-51.

Indexed at, Google Scholar, Crossref

9. R D Vanderlaan, C Manlhiot, L B Edwards, J Conway, B W McCrindle, et al. (2015) Risk factors for specific causes of death following pediatric heart transplant: An analysis of the registry of the International Society of Heart and Lung Transplantation. Pediatr Transplant 19: 896-905.

Indexed at, Google Scholar, Crossref

10. Sivathasan C, Lim CP, Kerk KL, Sim DK, Mehra MR, et al. (2017) Mechanical circulatory support and heart transplantation in the Asia Pacific region. J Heart Lung Transplant 36: 13-18.

Indexed at, Google Scholar, Crossref